Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Ntale, Muhammad ^a,b   Obua, Celestino ^a   Mukonzo, Jackson ^a   Mahindi, Margarita ^b   Gustafsson, Lars L ^b   Beck, Olof ^b   Ogwal Okeng, Jasper W ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOBIN; AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARINATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; DRUG METABOLITE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE AMODIAQUINE COMBINATION; ARTESUNATE-AMODIAQUINE COMBINATION;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FILTER; HUMAN; LIQUID CHROMATOGRAPHY; MALARIA FALCIPARUM; MALE; PAPER; PRESCHOOL CHILD; SCHOOL CHILD; ANIMAL; BLOOD; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; INFANT; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PARASITOLOGY; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME; UGANDA;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME; UGANDA;

EID: 65549094605     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-52     Document Type: Article

References (29)

1. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. AA Ashley K Stepniewska N Lindegrdh R McGready R Hutagalung T Singtoroj G Hla A Brockman S Proux J Wilahphaingern P Singhasivanon NJ White F Nosten, Trop Med Int Health 2007 12 201 208 17300626 (Pubitemid 46244169)
2. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. G Dorsey S Staedke TD Clark D Njama-Meya B Nzarubara C Maiteki-Sebuguzi C Dokomajilar MR Kamya PJ Rosenthal, Jama 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
3. Artemisinin-based combination treatment of falciparum malaria. F Nosten NJ White, Am J Trop Med Hyg 2007 77 181 192 18165491
4. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. SG Staedke P Jagannathan A Yeka H Bukirwa K Banek C Maiteki-Sebuguzi TD Clark B Nzarubara D Njama-Meya A Mpimbaza, Malar J 2008 7 107 18547416 10.1186/1475-2875-7-107
5. Pharmacovigilance of antimalarial treatment in Africa: is it possible? AO Talisuna SG Staedke U D'Alessandro, Malar J 2006 5 50 16780575 10.1186/1475-2875-5-50 (Pubitemid 44141482)
6. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. A Yeka G Dorsey MR Kamya A Talisuna M Lugemwa JB Rwakimari SG Staedke PJ Rosenthal F Wabwire-Mangen H Bukirwa, PLoS ONE 2008 3 e2390 18545692 10.1371/journal. pone.0002390
7. Systematic review of amodiaquine treatment in uncomplicated malaria. P Olliaro C Nevill J LeBras P Ringwald P Mussano P Garner P Brasseur, Lancet 1996 348 1196 1201 10.1016/S0140-6736(96)06217-4 8898036 (Pubitemid 26361606)
8. Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs. DJ Naisbitt DP Williams PM O'Neill JL Maggs DJ Willock M Pirmohamed BK Park, Chem Res Toxicol 1998 11 1586 1595 10.1021/tx980148k 9860505
9. Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design. DJ Naisbitt JE Ruscoe D Williams PM O'Neill M Pirmohamed BK Park, J Pharmacol Exp Ther 1997 280 884 893 9023303 (Pubitemid 27171352)
10. Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cells. JP Aymard B Rouveix R Ferry C Janot T May B Legras F Streiff, Acta Haematol 1989 82 40 42 10.1159/000205276 2505473
11. Amodiaquine-induced immune agranulocytosis. B Rouveix L Coulombel JP Aymard F Chau L Abel, Br J Haematol 1989 71 7 11 10.1111/j.1365-2141.1989. tb06266.x 2917131 (Pubitemid 19047689)
12. The in vitro effect of amodiaquine on bone marrow granulocyte-macrophage progenitor cells from normal subjects. JP Aymard C Wioland R Ferry P Netter F Streiff, Fundam Clin Pharmacol 1992 6 1 4 1555807
13. Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. MMWR Morb Mortal Wkly Rep 1986 35 165 166 3081784
14. Global AMDP database-Afro. WHO, WHO 2007
15. High perfomance liquid chromatographic assay for the simultaneous determination of sulfadoxine and pyrimethamine from whole blood dried on filter paper. MD Green DL Mount H Netty, J Chromatography B 2002 767 159 162 10.1016/S0378-4347(01)00547-3 (Pubitemid 34142347)
16. High performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples. OMS Minzi M Rais JO Svensson LL Gustafsson O Ericsson, J Chromatography B 2003 783 473 480 10.1016/S1570-0232(02)00727-4 (Pubitemid 35447998)
17. Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography. E Pussard F Verdier MC Blayo, J Chromatography 1986 374 111 118 10.1016/S0378-4347(00)83258-2 (Pubitemid 16189657)
18. Sensitive analysis of blood for amodiaquine and three metabolites by high-performance liquid chromatography with electrochemical detection. DL Mount LC Patchen P Nguyen-Dinh AM Barber IK Schwartz, J Chromatography 1986 383 375 386 10.1016/S0378-4347(00)83483-0 (Pubitemid 17224915)
19. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. EN Gitau SN Muchohi BR Ogutu IM Githiga GO Kokwaro, J Chromatography B 2004 799 173 177 10.1016/j.jchromb.2003.10.006 (Pubitemid 37500877)
20. Automated solid-phase extraction method for the determination of amodiaquine, chloroquine and their metabolites in capillary blood applied onto sampling paper by high-performance liquid chromatography. N Lindegrdh M Forslund MD Green A Kaneko Y Bergqvist, Chromatographia 2002 55 5 12 10.1007/BF02492307 (Pubitemid 34095147)
21. A field-adapted HPLC method for determination of amodiaquine and its metabolite in whole blood dried on filter paper. M Ntale M Mahindi JW Ogwal-Okeng LL Gustafsson O Beck, J Chromatography B 2007 859 137 140 10.1016/j.jchromb.2007.09.012 (Pubitemid 47626094)
22. WHO, Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva, Switzerland 1996
23. Antimalarial policy change to ACTs. National Malaria Control Programme - Uganda, Ministry of Health Kampala, Uganda 2006
24. The disposition of amodiaquine in man after oral administration. P Winstanley G Edwards M Orme A Breckenridge, Br J Clin Pharmacol 1987 23 1 7 3814460 (Pubitemid 17101817)
25. Amodiaquine for the treatment of uncomplicated falciparum malaria. P Olliaro W Taylor, WHO/CDS/TDR 2002
26. [Pharmacokinetics of amodiaquine and prevention of Plasmodium falciparum malaria]. E Pussard F Verdier F Faurisson MC Blayo, Bull Soc Pathol Exot Filiales 1985 78 959 964 3915449 (Pubitemid 16093528)
27. The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. FW Hombhanje I Hwaihwanje T Tsukahara J Saruwatari M Nakagawa H Osawa MM Paniu N Takahashi JK Lum B Aumora A Masta M Sapuri T Kobayakawa A Kaneko T Ishizaki, Br J Clin Pharmacol 2005 59 298 301 15752375 10.1111/j.1365-2125.2004.02257.x (Pubitemid 40388084)
28. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. FC Churchill LC Patchen CC Campbell IK Schwartz P Nguyen-Dinh CM Dickinson, Life Sci 1985 36 53 62 10.1016/0024- 3205(85)90285-1 3965841 (Pubitemid 15177094)
29. The disposition of amodiaquine in Zambians and Nigerians with malaria. PA Winstanley O Simooya JM Kofi-Ekue O Walker LA Salako G Edwards ML Orme AM Breckenridge, Br J Clin Pharmacol 1990 29 695 701 2378788 (Pubitemid 20183668)